Integrin alpha V beta 1

Integrin alpha V beta 1 Overview

English NameIntegrin alpha-V/beta-1Approved Drugs0
Drugs in Clinical Trials5Target Synonym
Highest Development StagePhase 2 Clinical
English NameIntegrin alpha-V/beta-1
Target Synonym
Approved Drugs0
Drugs in Clinical Trials5
Highest Development StagePhase 2 Clinical

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IDL-2965IDL-2965Phase 2 ClinicalIndalo Therapeutics IncIdiopathic Pulmonary Fibrosis; Metabolic Dysfunction-Associated Steatotic Liver Disease
Details
BexotegrastPLN-74809Phase 2 ClinicalPliant Therapeutics IncCholangitis, Sclerosing; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Respiratory Distress Syndrome, Adult
Details
PLN-1474PLN-1474Phase 1 ClinicalPliant Therapeutics IncLiver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease
Details
PLN-101095PLN-101095Phase 1 ClinicalPliant Therapeutics IncSolid tumours
Details
Cu-64-LLP2ACu-64-LLP2A; 64Cu-LLP2APhase 1 ClinicalUniversity Of PittsburghAnemia, Sickle Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Multiple Myeloma; Waldenstrom Macroglobulinemia
Details

Product Reviews

  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information